alexa Secondary Metabolites of Lichens as Both Anti-aggregative and Antioxidant Agents in Tauopathies | Open Access Journals
ISSN: 2155-9899
Journal of Clinical & Cellular Immunology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Secondary Metabolites of Lichens as Both Anti-aggregative and Antioxidant Agents in Tauopathies

Alberto Cornejo1* and Carlos Areche2

1Faculty of Medicine, School of Medical Technology, Andrés Bello University, Sazié 2315, Chile

2Department of Chemistry, Faculty of Sciences, University of Chile, Ñuñoa, Santiago 8320000, Chile

*Corresponding Author:
Alberto Cornejo
Faculty of Medicine, School of Medical Technology, Andrés Bello University
Sazié 2315, First Floor, Santiago 8370092, Chile
Tel: 56956351033
E-mail: [email protected]

Received date: February 01, 2017; Accepted date: March 30, 2017; Published date: April 11, 2017

Citation: Cornejo A, Areche C (2017) Secondary Metabolites of Lichens as Both Anti-aggregative and Antioxidant Agents in Tauopathies. J Clin Cell Immunol 8:496. doi: 10.4172/2155-9899.1000496

Copyright: © 2017 Cornejo A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical & Cellular Immunology

Abstract

This commentary described our findings of parietin, an anthraquinone, isolated from Ramalina terebrata as inhibitor of tau protein. Moreover, we considered important to link tauopathies with reactive oxygen species since oligomers and fibril-forming elements are responsible for activating reactive oxygen species, which cause inflammatory response and neurodegeneration. Together, we considered important to find naturally occurring compounds that might be able to stop aggregation and reduces ROS cells damage.

Keywords

Tauopathies; Secondary metabolites; Lichens; Reactive oxygen species; Inflammatory response; Neurodegeneration

Tauopathies and Neurotoxicity

Taoupathies are neurodegenerative disorders involving tau protein, such as progressive nuclear palsy (PSP), corticobasal degeneration (CBD), Pick´s disease among others. Tau is an unfolded protein which is found mainly in axons of mature and physiologically is involved in microtubule stability and axonal transport [1]. However, once tau becomes hyperphosphorylated it detaches from microtubule starting the aggregation process [2,3]. Pathological tau aggregates are able to activate glia cells that release cytotoxic factors, which cause pro inflammatory cytokines such as TNF-α, IL-1 and IL-6 and chemokines [4]. Tau phosphorylation is increased in both physiologically and pathological state [5], however phosphorylation is increased during development, suggesting that process is needed for neuronal plasticity [6]. Tau phosphorylation is an event highly regulated by kinases and phosphatases. Its balance is deregulated due to several stimuli such as oxidative stress [7]. Tau is able to form paired helical filaments closely related to neurofibrillary tangles [8,9]. Hyperphosphorylated tau protein is found in patients suffering with tauopathies in cerebrospinal fluid (CNS), which correlates well with hypocampal atrophy [10]. In addition, tauopathies have tau hyperphosphorylated as a hallmark; however, the degree of phosphorylation differs among them. In addition, it is important to notice that there is no single phosphorylation site associated to a particular tauopathy [5]. Moreover, tau has the propensity to form aggregates, since inside the full length protein (441 aminoacids) resides a region known as 4R (four microtubule binding domain) containing two hexapeptides 275VQIINK280 and 306VQIVYK311 both associated to β sheet formation [11]. Increased tau phosphorylation decreased its binding for microtubules. These species prone to form aggregates which are toxic in both cell and transgenic mouse model [12,13]. Despite that fact, there are evidences showing that soluble species and pre fibrils which are more related to toxicity [14]. An interesting UV raman spectroscopy study showed that at early stages, within the first hour, fibrillar aggregates possess a mixture of β-sheet and disordered content. Afterward, the UVRR spectra shows a consolidation in fibril structure, augmenting the content of β sheet [15], interesting is to remark that toxicity apparently relies on β sheet content [16].

Tauopathies and Reactive Oxygen Species

Reactive oxygen species (ROS) are reactive molecules such as hydroxyl (OH·), superoxide (O2·) and nitric monoxide (NO·). Besides, other molecules like hydrogen peroxide (H2O2) and peroxynitrite (ONOO) are not free radicals; however they are reported to generate free radicals [17,18].

In general, cells exposed to reactive oxygen species can overproduce free radicals that promotes oxidative damage on macromolecules, which can lead to pathological disorders such as stroke, chronic inflammation, also this species contribute to develop neurodegenerative disorders such as tauopathies. [18,19]. Once cells are in contact with toxic species, they are able to synthetize several enzymes in order to clear them, however residual superoxides and peroxides remain [18]. Moreover, there are evidences showing that ROS were first described in Pick´s disease and CBD [20]. It was also described that ROS associated to tauopathies, such as malondialdehyde (MDA) or 4-hydroxynonenal (HNE), a specie linked to polyunsaturated fatty acids. [21,22].

In contrast, antioxidants can prevent ROS that are able to induce injury. However, there are synthetic antioxidants that have shown either to induced cell toxicity or mutagenesis [23]. Thus it is timely to search for naturally occurring antioxidants. Hence, several antioxidant properties have been described associated to flavonoids, hydroxycinnamic derivatives, catechins, curcumin among others [24,25].

Importantly, the phenolic ring is the main moiety involved in scavenging ROS, metal chelator and modulates both the endogenous enzymatic-non enzymatic antioxidant system involved in neurodegenerative disorders including tauopathies [26].

Lichens as antioxidants and tau inhibitors source

Lichens are symbiotic association between a mycobiont (fungus) and either algae or cyanobacterium [27-29]. Besides lichens species are able to produce important secondary metabolites [30]. A remarkable feature of lichen species is their antioxidant capacity that resides in their phenolic moieties [31]. Interestingly, some depsides and depsidones isolated from lichens have shown antioxidant capacity [32-34]. Besides this, neuroprotective effect and cytotoxic potential have been described in Cetraria islandica and Vulpicida canadensis [35]. Two Xanthones isolated from Pyrenula japonica have a potent antioxidant capacity as compared with α-tocopherol and 2,6-di(tertbutyl)- 4-methylphenol (BHT) [36]. Moreover, ramalina isolated from Antartic Ramalina terebrata presented scavenging activity and it inhibits tyrosine enzyme activity. In addition, ramalina possess a very little toxicity in keratinocyte and fibroblast [37,38].

A β-orcinol depsidone, stictic acid and salazinic acid showed neuroprotective effect on U373MG cell line by diminishing ROS production. These compounds would be useful as antioxidant agents in Alzheimer´s disease [39], but it is important to notice that none of them have been tested as anti-tau inhibitor agent. Alternatively, a derivative plant polyphenol, curcumin, has been useful, since curcumin exerts a pleiotropic effect by combining both anti-aggregate and antioxidant activities.

Recently, we have characterized that parietin, an anthraquinone, isolated from Ramalina terebrata, lichen collected in the Antarctic region of “Península Fildes”, has effect on tau aggregation [40]. Docking studies of parietin and 306VQIVYK311 hexapeptide suggest that parietin bind steric zippers preventing β-sheet assembly [40]. According to the docking model, there are both types of interaction: hydrogen bond (HB) among phenolic groups, methoxy motif and lysine side chains. Besides this, hydrophobic interaction also occurs between methyl group of methoxy substituent and valine [40]. Interestingly, another anthraquinone, emodin, which inhibits tau aggregation has lower IC50 instead of parietin, we hypothesize that could be due to methoxy group at C-3 position in parietin (Figure 1). Moreover, another anthraquinone derived from plant, rhein, can reverse DNA methylation and de-suppression of Klotho, which has an essential role in anti-renal fibrosis in a mouse model [41,42]. Furthermore, in a senescence-accelerated mouse model, rhein reduces levels of Aβ [43], however both rhein and emodin are poorly active against Aβ in vitro aggregation assays [44]. Although, another anthraquinone, emodin, exerts profound effect over tau aggregation [45], and its scavenging capacity is lower as compared with alaternin [46], but there is no evidence that alaternin inhibits tau aggregation. Considering that oligomers or fibril-forming motif, exert their influence over inflammatory system, it would be interesting to find molecules isolated from natural sources that combine both anti-aggregative and scavenging properties, thus it would be a proper way to address drug design. In addition, it is interesting to mention that not only tauopathies exerts their damage on aggregation, since in neurodegenerative disorders such as Parkinson´s disease, α-synuclein is also prone to form aggregates and fibrils, and their toxicity is also linked to β sheet formation.

clinical-cellular-immunology-Anthraquinones-compound

Figure 1: Anthraquinones compound tau inhibitors. A) Parietin IC50 72 μM over tau four microtubule binding domain (4R). B) Emodin IC50 0.3 μM over tau K-18 construct.

Acknowledgments

This work was supported by grants from the INACH RT 13-13 to Alberto Cornejo and Carlos Areche.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 550
  • [From(publication date):
    April-2017 - Nov 22, 2017]
  • Breakdown by view type
  • HTML page views : 494
  • PDF downloads : 56
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords